Sirtuins in vascular diseases: Emerging roles and therapeutic potential

Biochimica Et Biophysica Acta
Nunzia D'OnofrioMaria Luisa Balestrieri

Abstract

Silent information regulator-2 (Sir-2) proteins, or sirtuins, are a highly conserved protein family of histone deacetylases that promote longevity by mediating many of the beneficial effects of calorie restriction which extends life span and reduces the incidence of cancer, cardiovascular disease (CVD), and diabetes. Here, we review the role of sirtuins (SIRT1-7) in vascular homeostasis and diseases by providing an update on the latest knowledge about their roles in endothelial damage and vascular repair mechanisms. Among all sirtuins, in the light of the numerous functions reported on SIRT1 in the vascular system, herein we discuss its roles not only in the control of endothelial cells (EC) functionality but also in other cell types beyond EC, including endothelial progenitor cells (EPC), smooth muscle cells (SMC), and immune cells. Furthermore, we also provide an update on the growing field of compounds under clinical evaluation for the modulation of SIRT1 which, at the state of the art, represents the most promising target for the development of novel drugs against CVD, especially when concomitant with type 2 diabetes.

References

Jun 30, 2000·Biochemical and Biophysical Research Communications·R A Frye
Mar 30, 2005·The Journal of Biological Chemistry·Gregory LisztLeonard Guarente
May 3, 2005·Journal of the American College of Cardiology·Gian Paolo FadiniAngelo Avogaro
Jan 28, 2006·Cell·Raul MostoslavskyFrederick W Alt
Apr 19, 2006·Genes & Development·Ethan FordLeonard Guarente
May 2, 2006·Genes & Development·Alejandro VaqueroDanny Reinberg
Sep 2, 2006·Cardiovascular Research·Louis J IgnarroClaudio Napoli
Feb 20, 2007·The Journal of Biological Chemistry·Eric van der VeerJ Geoffrey Pickering
May 22, 2007·Ageing Research Reviews·Matt Kaeberlein, R Wilson Powers
Sep 6, 2007·Proceedings of the National Academy of Sciences of the United States of America·Ilwola MattagajasinghKaikobad Irani
Oct 6, 2007·Journal of Molecular and Cellular Cardiology·Hidetaka OtaYasuyoshi Ouchi
Oct 17, 2007·Genes & Development·Michael PotenteStefanie Dimmeler
Nov 7, 2007·Journal of Biochemistry·Maria Luisa BalestrieriClaudio Napoli
Apr 22, 2008·Biochimica Et Biophysica Acta·Maria Luisa BalestrieriClaudio Napoli
Aug 5, 2008·International Journal of Cardiology·Paulo Roberto B EvoraVerena K Capellini
Oct 2, 2008·Nature Reviews. Drug Discovery·Siva LavuPhilip D Lambert
Jan 20, 2009·Current Pharmaceutical Design·Nica M Borradaile, J Geoffrey Pickering
Sep 3, 2009·American Journal of Physiology. Endocrinology and Metabolism·Yu YamazakiKazuyuki Tobe
Oct 17, 2009·Biochemical and Biophysical Research Communications·Fortunato ScaleraStefanie M Bode-Böger
Nov 13, 2009·Diabetes Care·Daniele VersariStefano Taddei
Jan 12, 2010·Biochimica Et Biophysica Acta·Jing-Yi HuangEric Verdin
Jan 19, 2010·Annual Review of Pathology·Marcia C Haigis, David A Sinclair
Jan 28, 2010·The Journal of Pharmacology and Experimental Therapeutics·Jason A FunkRick G Schnellmann
Mar 11, 2010·Journal of Atherosclerosis and Thrombosis·Hidetaka OtaYasuyoshi Ouchi
Apr 29, 2010·American Journal of Physiology. Endocrinology and Metabolism·Ting ZhaoAlex F Chen
May 11, 2010·Archives of Biochemistry and Biophysics·Sangwoon ChungIrfan Rahman
May 19, 2010·Proceedings of the National Academy of Sciences of the United States of America·Zhen ChenJohn Y-J Shyy
Jul 6, 2010·Biochimica Et Biophysica Acta·Antoni CaminsMercè Pallàs
Jul 14, 2010·Antioxidants & Redox Signaling·Peter Storz
Oct 27, 2010·Nature Communications·Daniel HerranzManuel Serrano
Dec 21, 2010·American Journal of Physiology. Heart and Circulatory Physiology·Catherine A LemariéErnesto L Schiffrin
Jan 26, 2011·Annals of the New York Academy of Sciences·Ketan R PatelKaren Brown
Feb 5, 2011·Cell Cycle·Sokrates Stein, Christian M Matter
Feb 18, 2011·Transcription·Lei Zhong, Raul Mostoslavsky
Apr 9, 2011·Circulation Research·Li LiChih-Chuan Liang
Jun 17, 2011·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Aiko Hashimoto-KomatsuKoichi Node

❮ Previous
Next ❯

Citations

Nov 20, 2015·The Journal of Pharmacology and Experimental Therapeutics·Gnanapragasam ArunachalamHong Ding
Mar 8, 2016·The Canadian Journal of Cardiology·Yujiro Kida, Michael S Goligorsky
Sep 4, 2015·Translational Psychiatry·L Lo IaconoV Carola
Jun 24, 2015·Age·Gaia FaveroRita Rezzani
Apr 24, 2016·Journal of Vascular Surgery·Naoki FujimuraRonald L Dalman
Jun 18, 2016·Stem Cells International·Cai-Guo YuDong Zhao
Feb 19, 2016·Molecular Nutrition & Food Research·Asimina Kerimi, Gary Williamson
Nov 10, 2016·Ageing Research Reviews·Milena VitielloMaria Luisa Balestrieri
Jan 28, 2017·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Soniya CharlesKanchana Mala
Apr 5, 2017·Journal of Cardiovascular Pharmacology·Luigi ServilloMaria Luisa Balestrieri
Jul 1, 2017·Antioxidants & Redox Signaling·Nunzia D'OnofrioMaria Luisa Balestrieri
May 29, 2016·American Journal of Physiology. Lung Cellular and Molecular Physiology·Eva Nozik-GrayckFrederick E Domann
Jun 16, 2017·Physiology·Naoki Sawada, Zolt Arany
Jan 9, 2019·Antioxidants & Redox Signaling·Sergey I Dikalov, Anna E Dikalova
Mar 3, 2018·Pediatric Cardiology·Alessandro IanniThomas Braun
Nov 6, 2018·Journal of Cellular Biochemistry·Sadiya Bi ShaikhYashodhar Prabhakar Bhandary
Dec 15, 2015·Journal of Cardiovascular Pharmacology·Yumeng GuoYu Wang
Oct 9, 2019·International Journal of Molecular Sciences·Maria de Céu TeixeiraEliana B Souto
Jun 6, 2020·Scandinavian Cardiovascular Journal : SCJ·Anders HovlandKnut Tore Lappegård
Nov 25, 2016·Neurochemical Research·Henryk JęśkoJoanna B Strosznajder
Mar 8, 2017·Oxidative Medicine and Cellular Longevity·Cheng LiJian Sun
Sep 12, 2018·Apoptosis : an International Journal on Programmed Cell Death·Debashri MannaRita Ghosh
Dec 19, 2018·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Salvatore SotgiaArduino A Mangoni
Nov 1, 2017·Frontiers in Endocrinology·Madhu KhullarSatish K Raut
Dec 3, 2016·Cell Death and Differentiation·Alexandre ProlaChristophe Lemaire
Dec 29, 2020·Bioorganic & Medicinal Chemistry·Semih YagciGokcen Eren
Apr 4, 2021·International Journal of Molecular Sciences·Marcin BasiakBogusław Okopień
Feb 23, 2020·Mechanisms of Ageing and Development·Cui ChenXiaobo Wang
May 25, 2021·British Journal of Pharmacology·Jefferson A LeiteNiels O S Câmara
Jul 3, 2021·European Journal of Pharmacology·Agnieszka StelmaszykMarzena Dworacka
Aug 9, 2020·Aging and Disease·Lijun ZhaoLimin Han

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Metabolism

In order for cancer cells to maintain rapid, uncontrolled cell proliferation, they must acquire a source of energy. Cancer cells acquire metabolic energy from their surrounding environment and utilize the host cell nutrients to do so. Here is the latest research on cancer metabolism.

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Adult Stem Cells

Adult stem cells reside in unique niches that provide vital cues for their survival, self-renewal, and differentiation. They hold great promise for use in tissue repair and regeneration as a novel therapeutic strategies. Here is the latest research.

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.

Cardiovascular Risk Prediction

Cardiovascular risk prediction models based on classical risk factors identified in epidemiological studies are useful in primary prevention of cardiovascular disease in individuals. Here is the latest research.

Cell Adhesion Molecules in AS

Cell adhesion molecules expressed on the vascular endothelium and circulating leukocytes in response to inflammatory stimuli are implicated in atherosclerosis. Here is the latest research.

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Cardiovascular Disorder in Diabetes

Diabetes is associated with an increased risk of cardiovascular disorders and heart failure. Discover the latest research here.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Related Papers

EMBO Molecular Medicine
Gizem Donmez, Tiago Fleming Outeiro
Biochimica Et Biophysica Acta
Turki Y AlhazzaziYvonne L Kapila
Frontiers in Pharmacology
Rita Machado de OliveiraTiago Fleming Outeiro
© 2021 Meta ULC. All rights reserved